NOT-CA-17-095: Notice of NCI's participation on PAR-17-474, Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21)

Notice of NCI's participation on PAR-17-474 "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21)"

Notice Number: NOT-CA-17-095

Key Dates
Release Date: October 6, 2017

Related Announcements
PAR-17-474

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) is participating in PAR-17-474, "Reducing Stigma to Improve HIV/AIDS Prevention, Treatment, and Care in Low and Middle-Income Countries (R21)."

The following changes have been made to reflect NCI's participation in this FOA:

Part 1. Overview Information

Components of Participating Organizations

Fogarty International Center (FIC)
National Institute of Mental Health (NIMH)
National Cancer Institute (NCI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.989, 93.242, 93.393, 93.394, 93.395, 93.399

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

[This section is appended with following statement of NCI's interests.]

In addition to research areas listed in the Funding Opportunity Description, NCI is interested in applications that address the following scientific gaps:

Evidence-based studies to reduce cancer stigma associated with strategies for behavioral changes of modifiable risk factors (e.g., smoking, obesity, alcohol use, diet) in people living with HIV/AIDS (PLWH);
Develop interventions to recognize and address stigma among healthcare providers, home care specialists, and caregivers for cancer patients living with HIV/AIDS;
Studies that enhance our understanding of the role stigma plays in accessing cancer screening and care as well as its impact on survivorship;
Develop and test tools that reduce stigma for PLWH and cancer that enhance palliation and end-of-life decisions across the care continuum; and
Develop interventions to improve patient - healthcare provider communication and educate hospice workers, home care specialists, and caregivers.

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contacts

Vidya Vedham, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7272
Email: [email protected]

Financial/Grants Management Contact(s)

Sean Hine
National Cancer Institute (NCI)
Telephone: 240-276-6291
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Vidya Vedham, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-7272
Email: [email protected]